Drug
Brodalumab
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Psoriatic Arthropathy | 173 | 45.3 | 49.5 | signal |
| 2 | Psoriasis | 498 | 40.1 | 53.0 | signal |
| 3 | Disease Recurrence | 137 | 30.2 | 32.3 | signal |
| 4 | Oral Candidiasis | 27 | 21.8 | 22.1 | signal |
| 5 | Intentional Dose Omission | 56 | 21.5 | 22.1 | signal |
| 6 | Therapy Interrupted | 136 | 20.7 | 22.1 | signal |
| 7 | Intentional Product Use Issue | 172 | 20.5 | 22.4 | signal |
| 8 | Insurance Issue | 28 | 19.8 | 20.1 | signal |
| 9 | Therapy Cessation | 87 | 17.9 | 18.6 | signal |
| 10 | Skin Infection | 19 | 17.9 | 18.0 | signal |
| 11 | Skin Laceration | 13 | 12.6 | 12.7 | signal |
| 12 | Pharyngitis Streptococcal | 12 | 11.6 | 11.7 | signal |
| 13 | Therapeutic Product Effect Decreased | 47 | 11.1 | 11.4 | signal |
| 14 | Dermatitis Contact | 12 | 11.1 | 11.2 | signal |
| 15 | Dizziness Postural | 10 | 10.9 | 11.0 | signal |
| 16 | Uveitis | 13 | 10.1 | 10.2 | signal |
| 17 | Localised Infection | 23 | 10.0 | 10.1 | signal |
| 18 | Knee Operation | 9 | 9.7 | 9.8 | signal |
| 19 | Body Temperature Decreased | 9 | 9.5 | 9.5 | signal |
| 20 | Gait Inability | 30 | 9.5 | 9.6 | signal |
| 21 | Pharyngitis | 11 | 9.3 | 9.3 | signal |
| 22 | Cellulitis | 42 | 8.7 | 8.9 | signal |
| 23 | Skin Haemorrhage | 12 | 8.7 | 8.8 | signal |
| 24 | Inability To Afford Medication | 8 | 8.5 | 8.6 | signal |
| 25 | Eye Infection | 9 | 8.4 | 8.5 | signal |
| 26 | Candida Infection | 13 | 8.2 | 8.2 | signal |
| 27 | Folliculitis | 8 | 8.1 | 8.2 | signal |
| 28 | Product Dose Omission In Error | 20 | 7.8 | 7.9 | signal |
| 29 | Gout | 13 | 7.6 | 7.6 | signal |
| 30 | Ear Infection | 19 | 7.5 | 7.6 | signal |
| 31 | Product Availability Issue | 16 | 7.5 | 7.5 | signal |
| 32 | Inflammatory Bowel Disease | 7 | 7.5 | 7.5 | signal |
| 33 | Musculoskeletal Chest Pain | 11 | 7.4 | 7.5 | signal |
| 34 | Therapeutic Product Effect Incomplete | 50 | 7.4 | 7.6 | signal |
| 35 | Emphysema | 7 | 7.3 | 7.3 | signal |
| 36 | Inappropriate Schedule Of Product Administration | 120 | 7.1 | 7.5 | signal |
| 37 | Hepatitis C | 8 | 6.9 | 6.9 | signal |
| 38 | Cyst | 8 | 6.8 | 6.8 | signal |
| 39 | Ill-defined Disorder | 39 | 6.7 | 6.8 | signal |
| 40 | Oropharyngeal Pain | 58 | 6.6 | 6.7 | signal |
| 41 | Feeling Cold | 17 | 6.4 | 6.4 | signal |
| 42 | Tooth Infection | 8 | 6.4 | 6.4 | signal |
| 43 | Skin Disorder | 20 | 6.3 | 6.4 | signal |
| 44 | Sars-cov-2 Test Positive | 8 | 6.3 | 6.3 | signal |
| 45 | Stress | 43 | 6.3 | 6.4 | signal |
| 46 | Skin Lesion | 16 | 6.2 | 6.2 | signal |
| 47 | Skin Fissures | 11 | 6.1 | 6.1 | signal |
| 48 | Lymphoma | 9 | 6.1 | 6.1 | signal |
| 49 | Knee Arthroplasty | 12 | 6.0 | 6.1 | signal |
| 50 | Surgery | 33 | 6.0 | 6.1 | signal |
| 51 | Tooth Extraction | 7 | 5.9 | 5.9 | signal |
| 52 | Treatment Failure | 46 | 5.9 | 6.0 | signal |
| 53 | Arthritis | 44 | 5.9 | 6.0 | signal |
| 54 | Suicidal Ideation | 51 | 5.8 | 6.0 | signal |
| 55 | Oral Pain | 12 | 5.6 | 5.6 | signal |
| 56 | Hip Arthroplasty | 8 | 5.5 | 5.5 | signal |
| 57 | Joint Range Of Motion Decreased | 7 | 5.5 | 5.5 | signal |
| 58 | Eye Haemorrhage | 7 | 5.5 | 5.5 | signal |
| 59 | Limb Injury | 14 | 5.4 | 5.5 | signal |
| 60 | Blood Iron Decreased | 6 | 5.3 | 5.4 | signal |
| 61 | Coronary Artery Occlusion | 7 | 5.3 | 5.3 | signal |
| 62 | Ligament Sprain | 5 | 5.3 | 5.3 | signal |
| 63 | Erectile Dysfunction | 13 | 5.3 | 5.3 | signal |
| 64 | Bladder Disorder | 5 | 5.3 | 5.3 | signal |
| 65 | Product Dose Omission Issue | 142 | 5.2 | 5.6 | signal |
| 66 | Carpal Tunnel Syndrome | 7 | 5.2 | 5.2 | signal |
| 67 | Toothache | 9 | 5.2 | 5.2 | signal |
| 68 | Tooth Disorder | 11 | 5.2 | 5.2 | signal |
| 69 | Covid-19 | 87 | 5.2 | 5.3 | signal |
| 70 | Photosensitivity Reaction | 8 | 5.1 | 5.1 | signal |
| 71 | Injection Site Discomfort | 5 | 5.1 | 5.1 | signal |
| 72 | Weight Fluctuation | 5 | 5.0 | 5.0 | signal |
| 73 | Immunodeficiency | 7 | 5.0 | 5.0 | signal |
| 74 | Arthralgia | 191 | 4.8 | 5.2 | signal |
| 75 | Blood Pressure Systolic Increased | 9 | 4.8 | 4.8 | signal |
| 76 | Immune System Disorder | 6 | 4.8 | 4.8 | signal |
| 77 | Depressed Mood | 24 | 4.8 | 4.8 | signal |
| 78 | Therapeutic Response Unexpected | 20 | 4.7 | 4.7 | signal |
| 79 | Eczema | 22 | 4.6 | 4.6 | signal |
| 80 | Arthropathy | 24 | 4.5 | 4.6 | signal |
| 81 | Influenza | 48 | 4.5 | 4.6 | signal |
| 82 | Sputum Discoloured | 4 | 4.4 | 4.4 | signal |
| 83 | Pericarditis | 7 | 4.4 | 4.4 | signal |
| 84 | Autoimmune Disorder | 4 | 4.4 | 4.4 | signal |
| 85 | Hernia | 8 | 4.4 | 4.4 | signal |
| 86 | Anosmia | 6 | 4.3 | 4.3 | signal |
| 87 | Spinal Operation | 5 | 4.3 | 4.3 | signal |
| 88 | Hypokinesia | 6 | 4.3 | 4.3 | signal |
| 89 | Mental Disorder | 18 | 4.3 | 4.4 | signal |
| 90 | Kidney Infection | 8 | 4.3 | 4.3 | signal |
| 91 | Hospitalisation | 62 | 4.3 | 4.4 | signal |
| 92 | Injection Site Mass | 15 | 4.3 | 4.3 | signal |
| 93 | Poisoning | 5 | 4.2 | 4.2 | signal |
| 94 | Eye Discharge | 4 | 4.1 | 4.1 | signal |
| 95 | Scratch | 4 | 4.1 | 4.1 | signal |
| 96 | Systemic Lupus Erythematosus | 13 | 3.9 | 3.9 | signal |
| 97 | Panic Attack | 13 | 3.7 | 3.8 | signal |
| 98 | Cholecystectomy | 4 | 3.7 | 3.7 | signal |
| 99 | Extra Dose Administered | 14 | 3.7 | 3.7 | signal |
| 100 | Accident | 4 | 3.5 | 3.5 | signal |
| 101 | Injection Site Urticaria | 8 | 3.5 | 3.5 | signal |
| 102 | Skin Cancer | 7 | 3.4 | 3.4 | signal |
| 103 | Pancreatic Carcinoma | 9 | 3.2 | 3.3 | signal |
| 104 | Sleep Disorder Due To A General Medical Condition | 5 | 3.2 | 3.2 | signal |
| 105 | Ankylosing Spondylitis | 4 | 3.2 | 3.2 | signal |
| 106 | Intentional Self-injury | 6 | 3.1 | 3.1 | signal |
| 107 | Acne | 21 | 2.9 | 2.9 | signal |
| 108 | Gastric Cancer | 7 | 2.9 | 2.9 | signal |
| 109 | Neoplasm Malignant | 18 | 2.8 | 2.8 | signal |
| 110 | Injection Site Bruising | 21 | 2.8 | 2.8 | signal |
| 111 | Dry Skin | 35 | 2.8 | 2.8 | signal |
| 112 | Procedural Pain | 7 | 2.7 | 2.7 | signal |
| 113 | Schizophrenia | 3 | 2.6 | 2.6 | no signal |
| 114 | Tuberculosis | 3 | 2.4 | 2.4 | no signal |
| 115 | Product Dose Omission | 15 | 2.4 | 2.4 | signal |
| 116 | Injection Site Pain | 66 | 2.3 | 2.3 | signal |
| 117 | Blood Glucose Abnormal | 4 | 2.3 | 2.3 | no signal |
| 118 | Needle Issue | 6 | 2.2 | 2.2 | no signal |
| 119 | Drug Effect Incomplete | 7 | 2.0 | 2.0 | no signal |
| 120 | Circumstance Or Information Capable Of Leading To Medication Error | 6 | 1.9 | 1.9 | no signal |
| 121 | Bladder Cancer | 10 | 1.8 | 1.8 | no signal |
| 122 | Synovitis | 3 | 1.7 | 1.7 | no signal |
| 123 | Product Storage Error | 13 | 1.6 | 1.6 | no signal |
| 124 | Abortion Spontaneous | 6 | 1.6 | 1.6 | no signal |
| 125 | Prostate Cancer | 11 | 1.4 | 1.4 | no signal |
| 126 | Oesophageal Carcinoma | 4 | 1.4 | 1.4 | no signal |
| 127 | Hepatic Cancer | 3 | 1.3 | 1.3 | no signal |
| 128 | Injection Site Swelling | 9 | 1.2 | 1.2 | no signal |
| 129 | Injection Site Haemorrhage | 8 | 1.1 | 1.1 | no signal |
| 130 | Breast Cancer | 9 | 1.0 | 1.0 | no signal |
| 131 | Device Dislocation | 4 | 1.0 | 1.0 | no signal |